Current Rheumatology Reports

, Volume 6, Issue 2, pp 96–97 | Cite as

Treatment guidelines for ankylosing spondylitis

  • Christopher T. Ritchlin
Clinical Trials Report


  1. 1.
    Ritchlin CT, Daikh BE: Recent advances in the treatment of the seronegative spondyloarthropathies. Curr Rheumatol Rep 2001, 3:399–403.PubMedCrossRefGoogle Scholar
  2. 2.
    Braun J, Brandt J, Listing J, et al.: Treatment of active ankylosing spondylitis with infliximab: a randomized controlled multicentre trial. Lancet 2002, 359:1187–1193.PubMedCrossRefGoogle Scholar
  3. 3.
    Gorman JD, Sack KE, Davis JC Jr.: Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha [comment]. N Engl J Med 2002, 346:1349–1356.PubMedCrossRefGoogle Scholar
  4. 4.
    Braun J, Baraliakos X, Golder W, et al.: Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum 2003, 48:1126–1136.PubMedCrossRefGoogle Scholar
  5. 5.
    Marzo-Ortega H, McGonagle D, O’Connor P, Emery P: Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study [comment]. Arthritis Rheum 2001, 44:2112–2117.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc. 2004

Authors and Affiliations

  • Christopher T. Ritchlin

There are no affiliations available

Personalised recommendations